The Akt/mTOR pathway in cancer stem/progenitor cells is a potential therapeutic target for glioblastoma and neuroblastoma.

Oncotarget · 2018 · PMC6173359 · PMID 30323898

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

P -values of p < 0.01 ( ** ) and p < 0.001 ( *** ) were considered significant and highly significant, respectively.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.